- Home
- DT vs CHWY Comparison
DT vs CHWY Comparison
Compare DT & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DT | CHWY |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Catalog/Specialty Distribution |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.0B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DT | CHWY |
|---|---|---|
| Price | $39.84 | $24.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 23 |
| Target Price | ★ $52.83 | $44.82 |
| AVG Volume (30 Days) | 5.6M | ★ 7.0M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 205.77 | ★ 911.11 |
| EPS | ★ 0.48 | 0.43 |
| Revenue | $1,698,683,000.00 | ★ $11,861,335,000.00 |
| Revenue This Year | $21.74 | $8.37 |
| Revenue Next Year | $14.85 | $8.28 |
| P/E Ratio | $82.85 | ★ $58.55 |
| Revenue Growth | ★ 18.75 | 6.40 |
| 52 Week Low | $33.24 | $23.06 |
| 52 Week High | $57.55 | $48.62 |
Technical Indicators
Market Signals| Indicator | DT | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 60.29 | 40.87 |
| Support Level | $38.50 | $23.06 |
| Resistance Level | $41.62 | $34.72 |
| Average True Range (ATR) | 1.32 | 1.05 |
| MACD | 0.42 | 0.07 |
| Stochastic Oscillator | 90.41 | 9.69 |
Price Performance
Historical ComparisonAbout DT Dynatrace Inc.
Dynatrace is a software-as-a-service company that enables customers to monitor and analyze their information technology infrastructure, from servers to applications and Python scripts. Dynatrace's unified platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to optimize their business for service-level objectives and ensure uptime.
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.